FRIEDMAN PAUL A sold MDGL
August 13, 2025 · Form 4 insider transaction
FRIEDMAN PAUL A sold 7,992 shares of Madrigal Pharmaceuticals, Inc. at $369.44 per share, a transaction worth $2.95M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,992
Price
$369.44
Total value
$2.95M
InsiderFRIEDMAN PAUL A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2025
Filing dateAugust 13, 2025
Shares owned after275,048
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $368.90 to $369.88, inclusive.